Walt Lab

The Walt lab pioneered the microwell array-based platforms for ultrasensitive biomarker detection and is now working towards new diagnostic approaches and translating them into products that can non-invasively and more accurately diagnose and assess the states of certain forms of cancer, infectious and neurodegenerative diseases. The technique, known as Single Molecule Arrays (Simoa), utilizes a novel digital readout method and can be used to detect proteins, post-translational modifications, microRNAs and biologically relevant small molecules. Most importantly, Simoa has the ability to improve the limit of detection of conventional enzyme-linked immunosorbent assay (ELISA) by 100-1000 fold. This increased sensitivity is critical for early disease diagnostics and for detecting differences between patients and healthy subjects that may be unobservable by other technologies.

 

Group News:

  • 2019/06: Our lab has openings for several research assistant positions. See the links below for more details:

https://partners.taleo.net/careersection/ex/jobdetail.ftl?job=3096975&tz=GMT-04%3A00&tzname=America%2FNew_York&lang=en#.XPb42sbx_lM.twitter

https://sjobs.brassring.com/TGnewUI/Search/home/HomeWithPreLoad?PageType=JobDetails&partnerID=25240&siteID=5341&AReq=48885BR#jobDetails=1452864_5341

   

Privacy Policy